357 related articles for article (PubMed ID: 26607864)
1. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
Riquelme JA; Westermeier F; Hall AR; Vicencio JM; Pedrozo Z; Ibacache M; Fuenzalida B; Sobrevia L; Davidson SM; Yellon DM; Sánchez G; Lavandero S
Pharmacol Res; 2016 Jan; 103():318-27. PubMed ID: 26607864
[TBL] [Abstract][Full Text] [Related]
2. The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts.
Deng L; Chen H; Wei N; Zhang Z; Wang G
Microvasc Res; 2019 May; 123():1-6. PubMed ID: 30179598
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Provides Cardioprotection During Early or Late Reperfusion Mediated by Different Mitochondrial K+-Channels.
Raupach A; Karakurt E; Torregroza C; Bunte S; Feige K; Stroethoff M; Brandenburger T; Heinen A; Hollmann MW; Huhn R
Anesth Analg; 2021 Jan; 132(1):253-260. PubMed ID: 32889843
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine protects mice against myocardium ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS pathway.
Sun Y; Jiang C; Jiang J; Qiu L
Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):946-953. PubMed ID: 28556946
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine Maintains Its Direct Cardioprotective Effect Against Ischemia/Reperfusion Injury in Hypertensive Hypertrophied Myocardium.
Yoshikawa Y; Hirata N; Kawaguchi R; Tokinaga Y; Yamakage M
Anesth Analg; 2018 Feb; 126(2):443-452. PubMed ID: 28914648
[TBL] [Abstract][Full Text] [Related]
7. Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury.
Bai J; Wang Q; Qi J; Yu H; Wang C; Wang X; Ren Y; Yang F
Phytomedicine; 2019 Oct; 63():153035. PubMed ID: 31377586
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury.
Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F
PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury.
Chen G; Xu C; Gillette TG; Huang T; Huang P; Li Q; Li X; Li Q; Ning Y; Tang R; Huang C; Xiong Y; Tian X; Xu J; Xu J; Chang L; Wei C; Jin C; Hill JA; Yang Y
Theranostics; 2020; 10(25):11754-11774. PubMed ID: 33052245
[No Abstract] [Full Text] [Related]
10. Key role of endothelium in the eNOS-dependent cardioprotection with exercise training.
Farah C; Nascimento A; Bolea G; Meyer G; Gayrard S; Lacampagne A; Cazorla O; Reboul C
J Mol Cell Cardiol; 2017 Jan; 102():26-30. PubMed ID: 27866931
[TBL] [Abstract][Full Text] [Related]
11. Involvement of GPR30 in protection effect of Dexmedetomidine against myocardial ischemia/reperfusion injury in rat via AKT pathway.
Shao Z; Shen Q; Kong M; Ni H; Hou X
Acta Biochim Pol; 2021 Feb; 68(1):119-126. PubMed ID: 33629579
[TBL] [Abstract][Full Text] [Related]
12. The vascular and cardioprotective effects of liriodenine in ischemia-reperfusion injury via NO-dependent pathway.
Chang WL; Chung CH; Wu YC; Su MJ
Nitric Oxide; 2004 Dec; 11(4):307-15. PubMed ID: 15604043
[TBL] [Abstract][Full Text] [Related]
13. The Cardioprotective Effect of Dexmedetomidine in Rats Is Dose-Dependent and Mediated by BKCa Channels.
Behmenburg F; Pickert E; Mathes A; Heinen A; Hollmann MW; Huhn R; Berger MM
J Cardiovasc Pharmacol; 2017 Apr; 69(4):228-235. PubMed ID: 28375904
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
[TBL] [Abstract][Full Text] [Related]
15. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
Kaneda K; Miyamae M; Sugioka S; Okusa C; Inamura Y; Domae N; Kotani J; Figueredo VM
Anesth Analg; 2008 Jan; 106(1):9-16, table of contents. PubMed ID: 18165545
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Preconditioning Attenuates Myocardial Ischemia/Reperfusion Injury in Rats by Suppressing Mitophagy Via Activating Α2-Adrenergic Receptor.
Chen Y; Chen H; Chen Y; Yang Z; Zhou T; Xu W
Arq Bras Cardiol; 2023 Oct; 120(10):e20220750. PubMed ID: 37909577
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart.
Ibacache M; Sanchez G; Pedrozo Z; Galvez F; Humeres C; Echevarria G; Duaso J; Hassi M; Garcia L; Díaz-Araya G; Lavandero S
Biochim Biophys Acta; 2012 Apr; 1822(4):537-45. PubMed ID: 22230708
[TBL] [Abstract][Full Text] [Related]
18. Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs.
Yoshitomi O; Cho S; Hara T; Shibata I; Maekawa T; Ureshino H; Sumikawa K
Shock; 2012 Jul; 38(1):92-7. PubMed ID: 22552015
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
